CSL Limited (CMXHF)
OTC Markets OTCQX - OTC Markets OTCQX Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 0.00 |
| Open | 193.28 |
| Bid | 192.25 x 3000 |
| Ask | 207.00 x 3100 |
| Day's range | 191.55 - 193.28 |
| 52-week range | 144.81 - 210.49 |
| Volume | |
| Avg. volume | 743 |
| Market cap | 97.798B |
| Beta (5Y monthly) | 0.32 |
| PE ratio (TTM) | 36.61 |
| EPS (TTM) | 5.46 |
| Earnings date | 13 Aug 2024 |
| Forward dividend & yield | 2.64 (1.32%) |
| Ex-dividend date | 09 Sept 2024 |
| 1y target est | N/A |
PR NewswireJapan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and sa-mRNA pioneer Arcturus Therapeutics today announced that Japan's Ministry of Health, Labor and Welfare (MHLWs) granted approval and authorization for their updated self-amplifying mRNA (sa-mRNA) COVID-19 vaccine, KOSTAIVE®. The updated vaccine is targeted to protect against the JN.1 lineage of Omicron subvariants for adults 18 years of age and older.
Simply Wall St.CSL (ASX:CSL) Ticks All The Boxes When It Comes To Earnings Growth
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
ZacksEXEL vs. CSLLY: Which Stock Should Value Investors Buy Now?
EXEL vs. CSLLY: Which Stock Is the Better Value Option?
© 2024 Yahoo. All rights reserved.